The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
A MicroRNA-29 Mimic (Remlarsen) Represses Extracellular Matrix Expression and Fibroplasia in the Skin
Open accessAbstract
MicroRNA-29 (miR-29) negatively regulates fibrosis and is downregulated in multiple fibrotic organs and tissues, including in the skin. miR-29 mimics prevent pulmonary fibrosis in mouse models but have not previously been tested in the skin. This study aimed to identify pharmacodynamic biomarkers of miR-29 in mouse skin, to translate those biomarkers across multiple species, and to assess the pharmacodynamic activity of a miR-29b mimic (remlarsen) in a clinical trial. miR-29 biomarkers were selected based on gene function and mRNA expression using quantitative reverse transcriptase polymerase chain reaction. Those biomarkers comprised multiple collagens and other miR-29 direct and indirect targets and were conserved across species; remlarsen regulated their expression in mouse, rat, and rabbit skin wounds and in human skin fibroblasts in culture, while a miR-29 inhibitor reciprocally regulated their expression. Biomarker expression translated to clinical proof-of-mechanism; in a double-blinded, placebo-randomized, within-subject controlled clinical trial of single and multiple ascending doses of remlarsen in normal healthy volunteers, remlarsen repressed collagen expression and the development of fibroplasia in incisional skin wounds. These results suggest that remlarsen may be an effective therapeutic to prevent formation of a fibrotic scar (hypertrophic scar or keloid) or to prevent cutaneous fibrosis, such as scleroderma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Self-citationMicro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
Roderburg, C., Urban, G.-W., Bettermann, K., Vucur, M., Zimmermann, H., Schmidt, S., Janssen, J., Koppe, C., Knolle, P., Castoldi, M., et al. (2011) · Hepatology · doi:10.1002/hep.23922 · Cited by 803
Biological Functions of miR-29b Contribute to Positive Regulation of Osteoblast Differentiation
Li, Z., Hassan, M. Q., Jafferji, M., Aqeilan, R. I., Garzon, R., Croce, C. M., van Wijnen, A. J., Stein, J. L., Stein, G. S., & Lian, J. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809787200 · Cited by 589
TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
Qin, W., Chung, A. C. K., Huang, X. R., Meng, X.-M., Hui, D. S. C., Yu, C.-M., Sung, J. J. Y., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121308 · Cited by 566
Fibrotic extracellular matrix activates a profibrotic positive feedback loop
Parker, M. W., Rossi, D., Peterson, M., Smith, K., Sikström, K., White, E. S., Connett, J. E., Henke, C. A., Larsson, O., & Bitterman, P. B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71386 · Cited by 548
MicroRNA‐29, a key regulator of collagen expression in systemic sclerosis
Maurer, B., Stanczyk, J., Jüngel, A., Akhmetshina, A., Trenkmann, M., Brock, M., Kowal‐Bielecka, O., Gay, R. E., Michel, B. A., Distler, J. H. W., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27443 · Cited by 539
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
Kriegel, A. J., Liu, Y., Fang, Y., Ding, X., & Liang, M. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00141.2011 · Cited by 533
miR-29 Is a Major Regulator of Genes Associated with Pulmonary Fibrosis
Cushing, L., Kuang, P. P., Qian, J., Shao, F., Wu, J., Little, F., Thannickal, V. J., Cardoso, W. V., & Lü, J. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0323oc · Cited by 502
MicroRNA-29 in Aortic Dilation: Implications for Aneurysm Formation
Boon, R. A., Seeger, T., Heydt, S., Fischer, A., Hergenreider, E., Horrevoets, A. J. G., Vinciguerra, M., Rosenthal, N., Sciacca, S., Pilato, M., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.255737 · Cited by 366
Gene Expression Profiles of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Konishi, K., Gibson, K. F., Lindell, K. O., Richards, T. J., Zhang, Y., Dhir, R., Bisceglia, M., Gilbert, S., Yousem, S. A., Song, J. W., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1596oc · Cited by 333
MicroRNAs in idiopathic pulmonary fibrosis
Pandit, K. V., Milosevic, J., & Kaminski, N. (2011) · Translational Research · doi:10.1016/j.trsl.2011.01.012 · Cited by 311
Micro RNA mimicry blocks pulmonary fibrosis
Montgomery, R. L., Yu, G., Latimer, P. A., Stack, C., Robinson, K., Dalby, C. M., Kaminski, N., & van Rooij, E. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303604 · Cited by 238
Self-citationLiu, Y., Taylor, N. E., Lu, L., Usa, K., Cowley, A. W., Ferreri, N. R., Yeo, N. C., & Liang, M. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.144428 · Cited by 235
Christmann, R. B., Sampaio‐Barros, P., Stifano, G., Borges, C. L., de Carvalho, C. R., Kairalla, R., Parra, E. R., Spira, A., Simms, R., Capellozzi, V. L., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38288 · Cited by 221
Hinchcliff, M., Huang, C.-C., Wood, T. A., Matthew Mahoney, J., Martyanov, V., Bhattacharyya, S., Tamaki, Z., Lee, J., Carns, M., Podlusky, S., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.130 · Cited by 186
Wei, W., He, H.-B., Zhang, W.-Y., Zhang, H.-X., Bai, J.-B., Liu, H.-Z., Cao, J.-H., Chang, K.-C., Li, X.-Y., & Zhao, S.-H. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.184 · Cited by 183
Suppression of hepatic stellate cell activation by microRNA-29b
Sekiya, Y., Ogawa, T., Yoshizato, K., Ikeda, K., & Kawada, N. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.041 · Cited by 168
Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4
Jiang, D., Liang, J., Campanella, G. S., Guo, R., Yu, S., Xie, T., Liu, N., Jung, Y., Homer, R., Meltzer, E. B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38644 · Cited by 159
Trompeter, H., Dreesen, J., Hermann, E., Iwaniuk, K. M., Hafner, M., Renwick, N. M., Tuschl, T., & Wernet, P. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-111 · Cited by 112
The role of miR-29 in pulmonary fibrosis
Cushing, L., Kuang, P., & Lü, J. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0095 · Cited by 112
NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer
Belle, V. A., McDermott, N., Meunier, A., & Marignol, L. H. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.195 · Cited by 108
MicroRNA array analysis of microRNAs related to systemic scleroderma
Li, H., Rong-ya, Y., Fan, X., Gu, T., Zhao, Z., Chang, D., Wang, W., & Wang, C. (2010) · Rheumatology International · doi:10.1007/s00296-010-1615-y · Cited by 88
MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6
Zhu, K., Liu, L., Zhang, J., Wang, Y., Liang, H., Fan, G., Jiang, Z., Zhang, C., Chen, X., & Zhou, G. (2016) · Protein & Cell · doi:10.1007/s13238-016-0277-2 · Cited by 81
Fibromodulin reduces scar formation in adult cutaneous wounds by eliciting a fetal-like phenotype
Zheng, Z. S., James, A. W., Li, C., Jiang, W., Wang, J. Z., Chang, G. X., Lee, K. S., Chen, F., Berthiaume, E. A., Chen, Y., et al. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.50 · Cited by 74
Cheng, J., Wang, Y., Wang, D., & Wu, Y. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318267680d · Cited by 63
Developing microRNA Therapeutics: Approaching the Unique Complexities
Jackson, A. L., & Levin, A. A. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0356 · Cited by 56
Self-citationMicroRNA-29: a potential therapeutic target for systemic sclerosis
Peng, W., Tao, J., Mei, B., Chen, B., Li, B., Yang, G., Zhang, Q., Yao, H., Wang, B., He, Q., et al. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.708339 · Cited by 56
A novel regulatory function for miR-29a in keloid fibrogenesis
Zhang, G.-Y., Wu, L., Liao, T., Chen, G.-C., Chen, Y.-H., Zhao, Y., Chen, S.-Y., Wang, A., Lin, K., Lin, D., et al. (2015) · Clinical and Experimental Dermatology · doi:10.1111/ced.12734 · Cited by 53
Zhu, Y., Li, Z.-W., Wang, Y.-L., Li, L., Wang, D.-M., Zhang, W., Liu, L., Jiang, H.-B., Yang, J.-R., & Cheng, J. (2016) · Translational Research: The Journal of Laboratory and Clinical Medicine · doi:10.1016/j.trsl.2016.07.001 · Cited by 45
Longmate, W. M., Lyons, S. P., Chittur, S. V., Pumiglia, K. M., Water, L. V. D., & DiPersio, C. M. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201510042 · Cited by 42
Sorting nexin 27 (SNX27) regulates the trafficking and activity of the glutamine transporter ASCT2
Yang, Z., Follett, J., Kerr, M. C., Clairfeuille, T., Chandra, M., Collins, B. M., & Teasdale, R. D. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000735 · Cited by 40
Aberrant localization of lamin B receptor (LBR) in cellular senescence in human cells
Arai, R., En, A., Ukekawa, R., Miki, K., Fujii, M., & Ayusawa, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.018 · Cited by 13
Cited by
Therapeutic siRNA: state of the art
Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0207-x · Cited by 1,586
Noncoding RNA therapeutics—Challenges and potential solutions
Winkle, M., El-Daly, S. M., Fabbri, M., & Calin, G. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00219-z · Cited by 1,551
Emerging concepts of miRNA therapeutics: from cells to clinic
Diener, C., Keller, A., & Meese, E. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.02.006 · Cited by 971
Non-coding RNAs in disease: from mechanisms to therapeutics
Nemeth, K., Bayraktar, R., Ferracin, M., & Calin, G. A. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-023-00662-1 · Cited by 885
The Dynamics of the Skin’s Immune System
Nguyen, A. V., & Soulika, A. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081811 · Cited by 694
Metadata
- Authors
- Gallant-Behm, C. L., Piper, J., Lynch, J. M., Seto, A. G., Hong, S. J., Mustoe, T. A., Maari, C., Pestano, L. A., Dalby, C. M., Jackson, A. L., Rubin, P., & Marshall, W. S.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 139
- Issue
- 5
- Pages
- 1073-1081
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2901270606
- Cited by
- 278
- References
- 32
- FWCI
- 14.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.